Brief: Cohance Lifesciences Says USFDA Completes CGMP Audit At Andhra Pradesh Facility
11/09/2025 16:31
Sept 11 (Reuters) - Cohance Lifesciences Ltd COHA.NS: COHANCE LIFESCIENCES LTD - USFDA COMPLETES CGMP AUDIT AT ANDHRA PRADESH FACILITY COHANCE LIFESCIENCES LTD - INSPECTION CONCLUDED WITH ZERO FORM 483 OBSERVATIONS Source text: ID:nBSEbgnF80 Further company coverage: COHA.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss